Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-Based Dual Therapy vs Quadruple Therapy for H. Pylori Eradication
NCT07179159Completed
- Start
- Sep 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vonoprazan and amoxicillin in Helicobacter pylori infection (3 arms). Primary endpoint: Helicobacter pylori eradication rate. Started Sep 2025; status: completed.
02
Drugs
vonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07179159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07179159.